These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12617894)
1. An adjustable release rate linking strategy for cytotoxin-peptide conjugates. Fuselier JA; Sun L; Woltering SN; Murphy WA; Vasilevich N; Coy DH Bioorg Med Chem Lett; 2003 Mar; 13(5):799-803. PubMed ID: 12617894 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery. Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents. Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Biological Activity of (20S,21S)-7-Cyclohexyl-21-fluorocamptothecin Carbamates as Potential Antitumor Agents. Ma H; Chen B; Wang Y; Wang C; Yao J; Zhang W; Miao Z Chem Biodivers; 2020 Jul; 17(7):e2000068. PubMed ID: 32342605 [TBL] [Abstract][Full Text] [Related]
5. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents. Sun L; Fuselier JA; Coy DH Drug Deliv; 2004; 11(4):231-8. PubMed ID: 15371104 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents. Hsieh HP; Liou JP; Lin YT; Mahindroo N; Chang JY; Yang YN; Chern SS; Tan UK; Chang CW; Chen TW; Lin CH; Chang YY; Wang CC Bioorg Med Chem Lett; 2003 Jan; 13(1):101-5. PubMed ID: 12467626 [TBL] [Abstract][Full Text] [Related]
7. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4. Aleksandrzak K; McGown AT; Hadfield JA Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of mustard derivatives of combretastatins. Coggiola B; Pagliai F; Allegrone G; Genazzani AA; Tron GC Bioorg Med Chem Lett; 2005 Aug; 15(15):3551-4. PubMed ID: 15963722 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4. Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804 [TBL] [Abstract][Full Text] [Related]
11. Conjugates of a novel 7-substituted camptothecin with RGD-peptides as α(v)β₃ integrin ligands: An approach to tumor-targeted therapy. Dal Pozzo A; Esposito E; Ni M; Muzi L; Pisano C; Bucci F; Vesci L; Castorina M; Penco S Bioconjug Chem; 2010 Nov; 21(11):1956-67. PubMed ID: 20949910 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins. Medarde M; Ramos AC; Caballero E; Peláez-Lamamié de Clairac R; López JL; Grávalos DG; Feliciano AS Bioorg Med Chem Lett; 1999 Aug; 9(16):2303-8. PubMed ID: 10476858 [TBL] [Abstract][Full Text] [Related]
14. Novel peptide conjugates for tumor-specific chemotherapy. Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents. Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949 [TBL] [Abstract][Full Text] [Related]
17. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles. Atwell GJ; Fan JY; Tan K; Denny WA J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents. Kamal A; Bajee S; Lakshma Nayak V; Venkata Subba Rao A; Nagaraju B; Ratna Reddy C; Jeevak Sopanrao K; Alarifi A Bioorg Med Chem Lett; 2016 Jun; 26(12):2957-2964. PubMed ID: 27161282 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues. Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ Bioorg Med Chem Lett; 2002 Aug; 12(15):1955-8. PubMed ID: 12113817 [TBL] [Abstract][Full Text] [Related]
20. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells. Moody TW; Fuselier J; Coy DH; Mantey S; Pradhan T; Nakagawa T; Jensen RT Peptides; 2005 Sep; 26(9):1560-6. PubMed ID: 16112393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]